U.S. Water Utilities Stock News

Intercontinental Exchange, Inc. ( NYSE:ICE ) shareholders are probably feeling a little disappointed, since its shares...

Shareholders will be ecstatic, with their stake up 70% over the past week following Meridian Holdings Inc. 's...

Last week, you might have seen that Sysco Corporation ( NYSE:SYY ) released its third-quarter result to the market. The...

As you might know, First Community Bankshares, Inc. ( NASDAQ:FCBC ) recently reported its quarterly numbers. It looks...

With the business potentially at an important milestone, we thought we'd take a closer look at Alpha Cognition Inc.'s...

Morningstar, Inc. ( NASDAQ:MORN ) defied analyst predictions to release its quarterly results, which were ahead of...

Insiders who bought Immuneering Corporation ( NASDAQ:IMRX ) in the last 12 months may probably not pay attention to the...

Last week saw the newest quarterly earnings release from Coca-Cola FEMSA, S.A.B. de C.V. ( NYSE:KOF ), an important...

Easterly Government Properties (DEA) has drawn attention after recent share price moves, with the stock showing an 11.4% gain over the past month and a 20.8% total return over the past year. See our latest analysis for Easterly Government Properties. The recent 11.4% 1 month share price return, alongside a 20.8% 1 year total shareholder return but weaker 3 and 5 year total shareholder returns, points to momentum building in the near term after a tougher longer run. If this kind of rebound has...

Camden Property Trust (CPT) opened 2026 with Q1 revenue of US$390.0 million, basic EPS of US$0.40 and net income of US$42.4 million, alongside Funds From Operations of US$122.9 million that many investors watch closely for a residential REIT. Over the past several quarters, revenue has moved from US$387.8 million in Q4 2024 to a range between US$393.1 million and US$399.2 million across 2025, while basic EPS has shifted between US$0.36 and US$1.44 over that same period. Taken together with a...

ResMed (RMD) has put up another solid quarter, with Q2 2026 revenue at about US$1.4b and basic EPS of US$2.69, while the trailing 12 month figures sit at US$5.4b of revenue and EPS of US$10.16. Over the past six reported quarters, revenue has moved from US$1,224.5m in Q1 2025 to US$1,422.8m in Q2 2026 and basic EPS has shifted from US$2.12 to US$2.69. This gives a clear view of the top line and per share earnings trend across the recent reporting run. With trailing 12 month earnings up 19%...

Last week saw the newest first-quarter earnings release from Omnicom Group Inc. ( NYSE:OMC ), an important milestone in...

Last week, you might have seen that Microsoft Corporation ( NASDAQ:MSFT ) released its third-quarter result to the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

UFP Industries, Inc. ( NASDAQ:UFPI ) just released its latest first-quarter report and things are not looking great. It...

Woodward, Inc. ( NASDAQ:WWD ) investors will be delighted, with the company turning in some strong numbers with its...

While Culp, Inc. ( NASDAQ:CULP ) might not have the largest market cap around , it received a lot of attention from a...

Some Northern Trust Corporation ( NASDAQ:NTRS ) shareholders may be a little concerned to see that the Executive VP...

Investors in Automatic Data Processing, Inc. ( NASDAQ:ADP ) had a good week, as its shares rose 9.0% to close at US$214...

Seanergy Maritime Holdings Corp. ( NASDAQ:SHIP ), is not the largest company out there, but it received a lot of...

Compañía de Minas BuenaventuraA (NYSE:BVN) reported multiple operational and permitting milestones in Q1 2026, including the production ramp up at San Gabriel. The company received key stage 1 operating and water use permits for San Gabriel, while Yumpag and El Brocal secured capacity expansion approvals. Gold production, company wide revenue, and profitability all saw significant gains in the quarter, alongside these project advances. For investors watching NYSE:BVN, these updates come...

Wondering whether Travere Therapeutics at around US$44.12 is still offering value or if the easy gains are already behind it? This article unpacks what the current price really implies. The stock has shown strong share price moves, with returns of 8.9% over 7 days, 40.4% over 30 days, 11.6% year to date, 108.6% over 1 year, 162.6% over 3 years and 120.5% over 5 years. This naturally raises questions about both upside potential and risk. Recent headlines around Travere Therapeutics have...

Bristol-Myers Squibb (BMY) opened 2026 with Q1 revenue of US$11.5b, basic EPS of US$1.31 and net income of US$2.7b, setting the tone for how investors will judge its recent profitability. The company has seen quarterly revenue move from US$11.2b and basic EPS of US$1.21 in Q1 2025 to US$11.5b and US$1.31 in Q1 2026. Trailing twelve month EPS reached US$3.57, giving a clearer read on earnings power over the last year. With trailing net profit margin at 15% and recent earnings growth of 34.2%...

Eastman Chemical Q1 2026 earnings: headline numbers in focus Eastman Chemical (EMN) has opened 2026 with Q1 revenue of US$2.2b and basic EPS of US$0.94, setting the stage for how investors assess the latest move in profitability. Over recent quarters the company has seen revenue move between US$2.0b and US$2.3b, with basic EPS ranging from US$0.41 to US$2.85, while trailing twelve month EPS sits at US$3.49 on revenue of US$8.6b. With the stock at US$77.53 and trailing net margin at 4.6%...